MYCOF News and Press, New Age Brands From 06/09/22

DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today provided an upd...

Mydecine Announces Closing of Overnight Marketed Public Offering of Units Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER , May 27, 2022 /CNW/ - Mydecine Innovations Group Inc. (" Myd...

Mydecine Overnight Marketed Public Offering of Units Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER , May 18, 2022 /CNW/ - Mydecine Innovations Group Inc. (" Mydecine " or the ...

Mydecine Innovations Group press release (OTCPK:MYCOF): Q1 GAAP EPS of -$1.20 misses by $0.41. As of March 31, 2022, the company had cash and cash equivalents of $0.26M. For further details see: Mydecine Innovations Group GAAP EPS of -$1.20 misses by $0.41

DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financi...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons , the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman says LSD and MDMA helped him alleviate symptoms rel...

Biotechnology company Mydecine Innovations Group (OTCPK:MYCOF) on Wednesday announced a 1-for-50 reverse stock split, wherein every 50 common shares will be consolidated into 1 common share. The reverse stock split is expected to result in Mydecine's outstanding common shares being reduced fr...

Mydecine Announces Reverse Stock-Split Canada NewsWire DENVER , April 13, 2022 /CNW/ - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (" Mydecine " or the " Company "), today announces its Board of Directors has voted in favo...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety med...

In 2021, Mydecine made significant progress in creating and commercializing new treatments for mental health and addiction disorders It also made a noteworthy shift in focus to reducing expenses and increasing efficiencies for continued clinical trials and the expansion of its IP portfo...